The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients

Saudi Medical Journal

Volumn 30, Issue 11, 2009, Pages 1439-1443

  Mosli, Hisham A ^a   Abdel Meguid, Taha A ^a   Al Maghrabi, Jaudah A ^b   Kamal, Wisam K ^a   Saadah, Hisham A ^b   Farsi, Hasan M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATITIS; SAUDI ARABIA; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COHORT STUDIES; ENDOSONOGRAPHY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; RISK ASSESSMENT; SAUDI ARABIA; SURVIVAL ANALYSIS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 70449645168     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mosli HA. Prostate cancer in Saudi Arabia in 2002. Saudi Med J 2003; 24: 573-581.
2. Stewart B, Kleihues P. The International Agency for Research on Cancer. World Cancer Report, International Agency for Research on Cancer. Lyon (FR): IARC Publication; 2003.
3. Al-Hamdan N, Ravichandraan K, Al-Sayyad J, Al-Lawati J, Khazal Z, Al-Khateeb F, et al. Incidence of cancer in Gulf Cooperation Council countries, 1998-2001. La Revuw de Sante de la Mediterranee Orientale 2009; 15: 600-611.
4. Al-Hamdan NA, Al-Zahrani A, Harper DM, Koriech O, Bazarbashi S. National Cancer Registry 1994 Report. In: Cancer incidence in Saudi Arabia. KSA: Ministry of Health; 1996. p. 25-26.
5. Mosli HA. Prostate Cancer in Saudi Arabia: Review of the literature (1975-1996). Ann Saudi Med 1997; 17: 510-514.
6. Al-Tamimi TM, Ibrahim EM, Ibrahim AW, Al-Bar AA, Assuhaimi SA, Gabriel GS, et al. Cancer in the Eastern Region of Saudi Arabia: A population-based study (1987-1988). Ann Saudi Med 1997; 17: 53-65.
7. Al-Otaibi KM, Al-Tartir T, Trabulsi FM. Predictive Parameters in Screening for Prostate Cancer. Proceedings of the 14th Saudi Urological Conference; 2001 Feb 13-15; Al-Khobar, KSA. Dhahran (KSA): King Fahd Military Medical Complex; 2001.
8. Chan JM. Epidemiology: Distribution and Determinants. In: Carroll PR, Grossfeld GD, editors. American Cancer Society Atlas of Clinical Oncology. Prostate Cancer. 1st ed. Ontario (Canada), London (UK): BC Decker Inc; 2002. p. 1-15.
9. Rizvi SAH, Naqvi SAA. The diagnosis and treatment of prostate cancer. Postgraduate Doctor Middle East 1997; 20: 58-64.
10. Taha SA, Kamal BA. Screening program for prostate cancer at a university hospital in eastern Saudi Arabia. Saudi Med J 2005; 26: 1104-1106.
11. Mosli HA. Incidental adenocarcinoma of the prostate: frequency rate at a tertiary care hospital. Ann Saudi Med 1997; 17: 662-664.
12. Boyle P, Maisonneuve P, Napalkov P. Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 1995; 46 (3 Suppl A): 47-55.
13. Hanash KA, Utz DC, Cook EN, Taylor WF, Titus JL. Carcinoma of the prostate: a 15-year follow up. J Urol 1972; 107: 450-453.
14. Jewett HJ. The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975; 2: 105-124.
15. Sheldon CA, Williams RD, Fraley EE. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 1980; 124: 626-631. (Pubitemid 11195763)
16. Smith JA Jr, Cho YH. Management of stage A prostate cancer. Urol Clin North Am 1990; 17: 769-777.
17. Tayib AM, Mosli HA, Al-Ammari AA. Results of prostate biopsies in a teaching hospital in Western Saudi Arabia. Saudi Med J 2003; 24: 859-862. (Pubitemid 37160631)
18. Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, et al. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower. Cancer 2008; 113: 2695-2703.
19. Jones JS, Follis HW, Johnson JR. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis 2009; 12: 57-60.
20. George E, Thomas S. A Histopathologic Survey of Prostate Disease in The Sultanate of Oman. The Internet Journal of Pathology; 2009. (updated 2009, July 11; accessed 2009 February 20). Available from URL: http://www.ispub.com/ journal/the-internet-journal-of-pathology/volume-3-number-2-41/article/ a-histopathologic-survey-of-prostate-disease-in-the-sultanate-of-oman.html